Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer

被引:39
|
作者
Watanabe, S [1 ]
Asamura, H [1 ]
Suzuki, K [1 ]
Tsuchiya, R [1 ]
机构
[1] Natl Canc Ctr, Div Thorac Surg, Tokyo 1040045, Japan
来源
ANNALS OF THORACIC SURGERY | 2005年 / 79卷 / 05期
关键词
D O I
10.1016/j.athoracsur.2004.11.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Clinical diagnosis of the nodal status is a significant factor in determining the treatment and predicting the prognosis in lung cancer patients. A patient with clinical N1 (cN1) disease is usually considered to be a candidate for surgical intervention in the present staging system in non-small cell lung cancer (NSCLC). However, cN1 disease is a subset for which the method of treatment and surgical results are variable, simply because both upstaging and downstaging can occur. We evaluated the surgical and pathologic results of cN1 NSCLC patients to reveal the problems in diagnosis and surgical management for this subset. Methods. From January 1998 to March 2003, 1,606 patients underwent thoracotomy for primary lung cancer at the National Cancer Center Hospital. Among them, the subjects for this study were 168 (10.5%) NSCLC patients who were clinically diagnosed as having N1 disease and underwent surgery without induction therapy. Results. The tumor cell types of these 168 cN1 NSCLC patients were adenocarcinoma in 73 (44%) and squamous cell carcinoma in 79 (47%). Pneumonectomy was performed in 26% (n = 43) patients, bilobectomy in 15% (n = 25), and exploratory thoracotomy in 11% (n = 19). Of 19 exploratory thoracotomy cases, 10 cases were due to pleural dissemination. The pathologic nodal status of the 135 patients who underwent pulmonary resection and mediastinal dissection was pN0, 19% (n = 25); pN1, 44% (n = 59); and pN2-3, 37% (n = 51). Of the 55 adenocarcinomas, 60% (n = 33) were revealed to be N2 disease on pathologic examination. There were no significant differences in the serum tumor markers between the pN1 and pN2 groups. Among the 25 patients who were down-staged postoperatively (cN1-pN0), 21 patients (84%) showed obstructive pneumonia in the lung. Conclusions. In the staging process of cN1 disease, it will be helpful to perform mediastinoscopy and thoracoscopy to avoid unnecessary thoracotomy especially in adenocarcinoma, even though mediastinal nodes and pleural dissemination were negative on computed tomography investigation. Since extensive pulmonary resection (bilobectomy or pneumonectomy) was required in 41% of the patients, preoperative detailed cardiopulmonary function tests should be mandatory to reduce surgical morbidity and mortality. On the other hand, when pneumonia due to airway obstruction by the tumor exists, false-positive hilar nodes can be expected. (c) 2005 by The Society of Thoracic Surgeons.
引用
收藏
页码:1682 / 1685
页数:4
相关论文
共 50 条
  • [41] The Impact of Induction Chemoradiotherapy Followed by Surgery for N1 Involved Non-Small Cell Lung Cancer
    Takahashi, Y.
    Soh, J.
    Miyauchi, S.
    Araki, K.
    Miura, A.
    Kurihara, E.
    Ogoshi, Y.
    Shien, K.
    Yamamoto, H.
    Sugimoto, S.
    Yamane, M.
    Kiura, K.
    Kanazawa, S.
    Toyooka, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S663 - S663
  • [42] Survival After Adjuvant Chemotherapy in Completely Resected N1 Non-Small Cell Lung Cancer
    Wang, E.
    Bourdages-Pageau, E.
    Gagnon, H.
    Labbe, C.
    Tremblay, L.
    Ugalde, P.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S633 - S633
  • [43] The Significance of N1 Lymph Node Involvement by Direct Extension for Non-Small Cell Lung Cancer
    Manyak, Grigory A.
    Hariri, Lida P.
    Auchincloss, Hugh G.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S487 - S488
  • [44] FACTORS INFLUENCING SURVIVAL OF PATIENT WITH PATHOLOGICAL PROVEN N1 NON-SMALL CELL LUNG CANCER
    Shinohara, Hirohiko
    Hashimoto, Takehisa
    Tsuchida, Masanori
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S886 - S887
  • [45] Eyelid Metastasis in Non-Small Cell Lung Cancer: Diagnosis and Management
    Joseph, Shannon S.
    Yentz, Sarah E.
    Mikkilineni, Shravani
    Nelson, Christine
    Kalemkerian, Gregory P.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2016, 129 (09): : E169 - E172
  • [46] Standard Mediastinoscopy Versus Video-Assisted Mediastinoscopic Lymphadectomy in Clinical N1 Non-Small Cell Lung Cancer
    Turna, A.
    Melek, H.
    Kara, H. V.
    Kilic, B.
    Kaynak, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S848 - S848
  • [47] Predictors for hilar/intrapulmonary lymph node metastasis in discrete type of clinical N1 non-small cell lung cancer
    Fukui, Takayuki
    Kato, Katsuhiko
    Okasaka, Toshiki
    Kawaguchi, Koji
    Fukumoto, Koichi
    Nakamura, Shota
    Hakiri, Shuhei
    Ozeki, Naoki
    Yokoi, Kohei
    [J]. GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2017, 65 (11) : 640 - 645
  • [48] Predictors for hilar/intrapulmonary lymph node metastasis in discrete type of clinical N1 non-small cell lung cancer
    Takayuki Fukui
    Katsuhiko Kato
    Toshiki Okasaka
    Koji Kawaguchi
    Koichi Fukumoto
    Shota Nakamura
    Shuhei Hakiri
    Naoki Ozeki
    Kohei Yokoi
    [J]. General Thoracic and Cardiovascular Surgery, 2017, 65 : 640 - 645
  • [49] MANAGEMENT OF N2 NON-SMALL CELL LUNG CANCER
    Shetty, Preethi S.
    Mankar, Hemant
    Pramesh, C. S.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 152 (05): : 1463 - 1464
  • [50] Phase I study of N1,N11-diethylnorspermine in patients with non-small cell lung cancer
    Hahm, HA
    Ettinger, DS
    Bowling, K
    Hoker, B
    Chen, TL
    Zabelina, Y
    Casero, RA
    [J]. CLINICAL CANCER RESEARCH, 2002, 8 (03) : 684 - 690